Navigation Links
Uses of medications in psychoanalysis
Date:1/9/2008

As Americans increasingly seek a quick fix to physical and mental ailments, psychoanalysts can be caught in the crossfire of a debate about the potential benefits and drawbacks of including medication in their treatment plans. A panel discussion entitled, The Uses of Medications in Psychoanalysis: What We Know; What is Uncertain, will be led by internationally renowned psychoanalyst Glen O. Gabbard, M.D., at the American Psychoanalytic Associations 2008 Winter Meeting. The panel discussion will be held on Friday, January 18, 2008, from 2-5 p.m. at the Waldorf Astoria Hotel in New York. Media are invited to attend.

Taking the position for a cautious approach to the inclusion of medications in analysis will be Stephen D. Purcell, M.D., whose paper titled The Analysts Attitude toward Pharmacotherapy will be published in the Journal of the American Psychoanalytic Association (JAPA) in 2008. Adele Tutter, M.D., Ph.D., is more optimistic about the inclusion of medications in treatment and her article, Medication as Object, was published in JAPA. The panel discussion will be chaired by Richard M. Gottlieb, M.D., and the discussant will be Dr. Gabbard.

Instead of perceiving the use of medications in competition with analysis, we should educate our patients about the potential costs and benefits of including medication in an analytic treatment. Then, patients can make informed decisions about their treatment options, says Dr. Tutter. While we analysts value insight and introspection, some patients dont value these things and should be allowed to choose.

Im not taking the position that combined treatments that include medication and analysis should not be done. Instead, I believe they must be considered very carefully, says Dr. Purcell. An analyst's decision to combine medication with a psychoanalysis is also a tacit communication that under some circumstances can be an interference to psychoanalytic processes of change. The panel discussion is open to members of the media, mental health practitioners, students, and the public.


'/>"/>

Contact: Dottie Jeffries
djeffries@apsa.org
212-752-0450 x29
American Psychoanalytic Association
Source:Eurekalert

Related medicine news :

1. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
2. Diet and medications may assist prevention of prostate cancer
3. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
4. Patients cant recall their medications to tell doctors
5. The American Pharmacists Association Supports Consumer Education About OTC Medications
6. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
7. Many Osteoporosis Medications Prevent Fractures, But None Is Proven Best
8. Cost of glaucoma medications may impact treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2017)... Edmonton, AB (PRWEB) , ... July 21, 2017 , ... ... a life insurance brokerage firm servicing Albertans,” says owner and licensed broker Nerissa McNaughton. ... health insurance can be difficult, but it is a very necessary conversation. I make ...
(Date:7/21/2017)... ... , ... "As a doctor of lung medicine managing chest diseases for more ... said an inventor from Center Valley, Pa. "My idea is to improve the device ... the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means of draining pleural ...
(Date:7/21/2017)... Augusta, GA (PRWEB) , ... July 21, 2017 , ... ... is teaming up with the Epilepsy Foundation in a community wide charity event with ... region. , Delaney Sunde, a young local woman who lives with epilepsy, recently launched ...
(Date:7/21/2017)... Minnesota (PRWEB) , ... July 21, 2017 , ... ... BWBR recently were selected to renovate and improve the Ramsey County Medical Examiners ... adjacent to Regions Hospital, the $2.5 million project is scheduled to start in ...
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed in the second quarter ... hospital acquisitions rose to 23 in the second quarter, up 15% from the 20 ... 20 announced deals in the year-ago second quarter. Only four of the transactions disclosed ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
(Date:6/30/2017)... SAN DIEGO , June 30, 2017  AVACEN Medical (AVACEN) ... Access Journal. The research describes the use of its AVACEN ... by those suffering from fibromyalgia. ... AVACEN Medical ... Fibromyalgia is characterized by chronic widespread pain. It affects approximately 200 to ...
(Date:6/27/2017)... 27, 2017   NuEyes (NuEyes Technologies Inc.) today ... fuel its growth in helping the legally blind live more ... Group), the leading developer of augmented, virtual and mixed reality ... The undisclosed funding amount was provided by strategic partners ... with offices in Abu Dhabi , ...
Breaking Medicine Technology: